Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome.

Arrondel C, Missoury S, Snoek R, Patat J, Menara G, Collinet B, Liger D, Durand D, Gribouval O, Boyer O, Buscara L, Martin G, Machuca E, Nevo F, Lescop E, Braun DA, Boschat AC, Sanquer S, Guerrera IC, Revy P, Parisot M, Masson C, Boddaert N, Charbit M, Decramer S, Novo R, Macher MA, Ranchin B, Bacchetta J, Laurent A, Collardeau-Frachon S, van Eerde AM, Hildebrandt F, Magen D, Antignac C, van Tilbeurgh H, Mollet G.

Nat Commun. 2019 Sep 3;10(1):3967. doi: 10.1038/s41467-019-11951-x.

2.

Social deprivation is associated with poor kidney transplantation outcome in children.

Driollet B, Bayer F, Chatelet V, Macher MA, Salomon R, Ranchin B, Roussey G, Lahoche A, Garaix F, Decramer S, Mérieau E, Fila M, Zaloszyc A, Deschênes G, Valeri L, Launay L, Couchoud C, Leffondré K, Harambat J.

Kidney Int. 2019 Sep;96(3):769-776. doi: 10.1016/j.kint.2019.05.011. Epub 2019 May 28.

PMID:
31375259
3.

Ultrasound dilution and thermodilution versus color Doppler ultrasound for arteriovenous fistula assessment in children on hemodialysis.

Karava V, Kwon T, Franco G, Georges D, Macher MA, Hogan J.

Pediatr Nephrol. 2019 Jul 19. doi: 10.1007/s00467-019-04297-5. [Epub ahead of print]

PMID:
31324981
4.

Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded criteria donors.

Savoye E, Macher MA, Videcoq M, Gatault P, Hazzan M, Abboud I, Thierry A, Bertrand D, Drouin S, Sayegh J, Barrou B, Badet L, Bastien O, Huot O, Lamotte C, Logerot H, Legeai C, Antoine C.

Clin Transplant. 2019 May;33(5):e13536. doi: 10.1111/ctr.13536. Epub 2019 Apr 10.

PMID:
30869162
5.

Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome.

Gasongo G, Greenbaum LA, Niel O, Kwon T, Macher MA, Maisin A, Baudouin V, Dossier C, Deschênes G, Hogan J.

Pediatr Nephrol. 2019 Apr;34(4):679-684. doi: 10.1007/s00467-018-4135-8. Epub 2018 Nov 13.

PMID:
30426218
6.

Building Kidney Exchange Programmes in Europe-An Overview of Exchange Practice and Activities.

Biró P, Haase-Kromwijk B, Andersson T, Ásgeirsson EI, Baltesová T, Boletis I, Bolotinha C, Bond G, Böhmig G, Burnapp L, Cechlárová K, Di Ciaccio P, Fronek J, Hadaya K, Hemke A, Jacquelinet C, Johnson R, Kieszek R, Kuypers DR, Leishman R, Macher MA, Manlove D, Menoudakou G, Salonen M, Smeulders B, Sparacino V, Spieksma FCR, Valentín MO, Wilson N, van der Klundert J; ENCKEP COST Action.

Transplantation. 2019 Jul;103(7):1514-1522. doi: 10.1097/TP.0000000000002432.

7.

Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.

Legeai C, Andrianasolo RM, Moranne O, Snanoudj R, Hourmant M, Bauwens M, Soares J, Jacquelinet C, Couchoud C, Macher MA.

Am J Transplant. 2018 Nov;18(11):2695-2707. doi: 10.1111/ajt.15110. Epub 2018 Oct 18.

PMID:
30203618
8.

Interdialytic weight gain and vasculopathy in children on hemodialysis: a single center study.

Karava V, Benzouid C, Kwon T, Macher MA, Deschênes G, Hogan J.

Pediatr Nephrol. 2018 Dec;33(12):2329-2336. doi: 10.1007/s00467-018-4026-z. Epub 2018 Sep 3.

PMID:
30178237
9.

Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.

Hogan J, Dossier C, Kwon T, Macher MA, Maisin A, Couderc A, Niel O, Baudouin V, Deschênes G.

Pediatr Nephrol. 2019 Feb;34(2):253-259. doi: 10.1007/s00467-018-4052-x. Epub 2018 Aug 14.

PMID:
30109447
10.

Impact of donor coronary angiography on kidney transplantation outcomes.

Lesouhaitier M, Legeai C, Savoye E, Cantrelle C, Pipien I, Macher MA, Vigneau C, Dorent R.

Clin Transplant. 2018 Sep;32(9):e13355. doi: 10.1111/ctr.13355. Epub 2018 Aug 9.

PMID:
30022530
11.

[Description of immunosuppressive maintenance treatments post kidney transplant through the National System of Health Insurance].

Sitruk L, Couchoud C, Hourmant M, Tuppin P, Macher MA, Legeai C.

Nephrol Ther. 2018 Dec;14(7):523-530. doi: 10.1016/j.nephro.2018.03.004. Epub 2018 Jun 8. French.

PMID:
29887268
12.

Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age.

Hogan J, Bacchetta J, Charbit M, Roussey G, Novo R, Tsimaratos M, Terzic J, Ulinski T, Garnier A, Merieau E, Harambat J, Vrillon I, Dunand O, Morin D, Berard E, Nobili F, Couchoud C, Macher MA; French Pediatric Nephrology Society.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1459-1465. doi: 10.1093/ndt/gfy040.

PMID:
29617835
13.

Treatment and outcome of congenital nephrotic syndrome.

Bérody S, Heidet L, Gribouval O, Harambat J, Niaudet P, Baudouin V, Bacchetta J, Boudaillez B, Dehennault M, de Parscau L, Dunand O, Flodrops H, Fila M, Garnier A, Louillet F, Macher MA, May A, Merieau E, Monceaux F, Pietrement C, Rousset-Rouvière C, Roussey G, Taque S, Tenenbaum J, Ulinski T, Vieux R, Zaloszyc A, Morinière V, Salomon R, Boyer O.

Nephrol Dial Transplant. 2019 Mar 1;34(3):458-467. doi: 10.1093/ndt/gfy015.

PMID:
29474669
14.

Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population.

Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dušek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ; ESPN/ERA-EDTA Registry.

Nephrol Dial Transplant. 2018 Mar 1;33(3):542. doi: 10.1093/ndt/gfx372. No abstract available.

PMID:
29340701
15.

Fluid status evaluation by inferior vena cava diameter and bioimpedance spectroscopy in pediatric chronic hemodialysis.

Torterüe X, Dehoux L, Macher MA, Niel O, Kwon T, Deschênes G, Hogan J.

BMC Nephrol. 2017 Dec 28;18(1):373. doi: 10.1186/s12882-017-0793-1.

16.

Autologous arteriovenous fistulas for hemodialysis using microsurgery techniques in children weighing less than 20 kg.

Karava V, Jehanno P, Kwon T, Deschênes G, Macher MA, Bourquelot P.

Pediatr Nephrol. 2018 May;33(5):855-862. doi: 10.1007/s00467-017-3854-6. Epub 2017 Dec 5.

PMID:
29209823
17.

Hypernatremia and acute pancreatitis in chronic kidney disease: back to the salt mines. Answers.

de Tersant M, Kwon T, Macher MA, Maisin A, Deschênes G, Niel O.

Pediatr Nephrol. 2018 Jul;33(7):1157-1158. doi: 10.1007/s00467-017-3824-z. Epub 2017 Oct 24. No abstract available.

PMID:
29067526
18.

Hypernatremia and acute pancreatitis in chronic kidney disease: back to the salt mines. Questions.

de Tersant M, Kwon T, Macher MA, Maisin A, Deschênes G, Niel O.

Pediatr Nephrol. 2018 Jul;33(7):1155-1156. doi: 10.1007/s00467-017-3821-2. Epub 2017 Oct 24.

PMID:
29067525
19.

Infection-related hospitalizations after kidney transplantation in children: incidence, risk factors, and cost.

Hogan J, Pietrement C, Sellier-Leclerc AL, Louillet F, Salomon R, Macher MA, Berard E, Couchoud C.

Pediatr Nephrol. 2017 Dec;32(12):2331-2341. doi: 10.1007/s00467-017-3737-x. Epub 2017 Jul 25.

PMID:
28744628
20.

Cinacalcet in hyperparathyroidism management after pediatric renal transplantation.

Niel O, Maisin A, Macher MA, Peuchmaur M, Deschênes G.

CEN Case Rep. 2016 Nov;5(2):141-143. doi: 10.1007/s13730-015-0211-0. Epub 2016 Jan 22.

21.

[Towards the development of living donor kidney transplantation].

Macher MA.

Rev Infirm. 2016 Dec;65(226):16-19. doi: 10.1016/j.revinf.2016.09.006. French.

PMID:
27908467
22.

Age-Dependent Risk of Graft Failure in Young Kidney Transplant Recipients.

Kaboré R, Couchoud C, Macher MA, Salomon R, Ranchin B, Lahoche A, Roussey-Kesler G, Garaix F, Decramer S, Pietrement C, Lassalle M, Baudouin V, Cochat P, Niaudet P, Joly P, Leffondré K, Harambat J.

Transplantation. 2017 Jun;101(6):1327-1335. doi: 10.1097/TP.0000000000001372.

PMID:
27482961
23.

Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.

Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.

Pediatr Nephrol. 2016 Nov;31(11):2095-101. doi: 10.1007/s00467-016-3400-y. Epub 2016 Jun 4.

PMID:
27263020
24.

Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.

Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C, Treard C, Baudouin V, Beltran S, Broux F, Camard O, Cloarec S, Cormier C, Debussche X, Dubosclard E, Eid C, Haymann JP, Kiando SR, Kuhn JM, Lefort G, Linglart A, Lucas-Pouliquen B, Macher MA, Maruani G, Ouzounian S, Polak M, Requeda E, Robier D, Silve C, Souberbielle JC, Tack I, Vezzosi D, Jeunemaitre X, Houillier P.

J Clin Endocrinol Metab. 2016 May;101(5):2185-95. doi: 10.1210/jc.2015-3442. Epub 2016 Mar 10.

PMID:
26963950
25.

Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting.

Forstner C, Diab-Elschahawi M, Kivaranovic D, Graninger W, Mitteregger D, Macher M, Wrba T, Presterl E.

Antimicrob Resist Infect Control. 2015 Jun 15;4:25. doi: 10.1186/s13756-015-0064-5. eCollection 2015.

26.

Renal function can be impaired in children with primary hyperoxaluria type 3.

Allard L, Cochat P, Leclerc AL, Cachat F, Fichtner C, De Souza VC, Garcia CD, Camoin-Schweitzer MC, Macher MA, Acquaviva-Bourdain C, Bacchetta J.

Pediatr Nephrol. 2015 Oct;30(10):1807-13. doi: 10.1007/s00467-015-3090-x. Epub 2015 May 14.

PMID:
25972204
27.

Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1.

Mansour-Hendili L, Blanchard A, Le Pottier N, Roncelin I, Lourdel S, Treard C, González W, Vergara-Jaque A, Morin G, Colin E, Holder-Espinasse M, Bacchetta J, Baudouin V, Benoit S, Bérard E, Bourdat-Michel G, Bouchireb K, Burtey S, Cailliez M, Cardon G, Cartery C, Champion G, Chauveau D, Cochat P, Dahan K, De la Faille R, Debray FG, Dehoux L, Deschenes G, Desport E, Devuyst O, Dieguez S, Emma F, Fischbach M, Fouque D, Fourcade J, François H, Gilbert-Dussardier B, Hannedouche T, Houillier P, Izzedine H, Janner M, Karras A, Knebelmann B, Lavocat MP, Lemoine S, Leroy V, Loirat C, Macher MA, Martin-Coignard D, Morin D, Niaudet P, Nivet H, Nobili F, Novo R, Faivre L, Rigothier C, Roussey-Kesler G, Salomon R, Schleich A, Sellier-Leclerc AL, Soulami K, Tiple A, Ulinski T, Vanhille P, Van Regemorter N, Jeunemaître X, Vargas-Poussou R.

Hum Mutat. 2015 Aug;36(8):743-52. doi: 10.1002/humu.22804. Epub 2015 Jun 11. Review.

PMID:
25907713
28.

Individual and regional factors of access to the renal transplant waiting list in france in a cohort of dialyzed patients.

Bayat S, Macher MA, Couchoud C, Bayer F, Lassalle M, Villar E, Caillé Y, Mercier S, Joyeux V, Noel C, Kessler M, Jacquelinet C; REIN registry.

Am J Transplant. 2015 Apr;15(4):1050-60. doi: 10.1111/ajt.13095. Epub 2015 Mar 10.

29.

Are there good reasons for inequalities in access to renal transplantation in children?

Hogan J, Audry B, Harambat J, Dunand O, Garnier A, Salomon R, Ulinski T, Macher MA, Couchoud C.

Nephrol Dial Transplant. 2015 Dec;30(12):2080-7. doi: 10.1093/ndt/gfu356. Epub 2014 Nov 23.

30.

The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.

Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, Godmer P, Abasq C, Astudillo L, Belenotti P, Bessis D, Bigot A, Doutre MS, Ebbo M, Guichard I, Hachulla E, Héron E, Jeudy G, Jourde-Chiche N, Jullien D, Lavigne C, Machet L, Macher MA, Martel C, Melboucy-Belkhir S, Morice C, Petit A, Simorre B, Zenone T, Bouillet L, Bagot M, Frémeaux-Bacchi V, Guillevin L, Mouthon L, Dupin N, Aractingi S, Terrier B; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Feb;67(2):527-34. doi: 10.1002/art.38956.

31.

Rapid access to renal transplant waiting list in children: impact of patient and centre characteristics in France.

Hogan J, Savoye E, Macher MA, Bachetta J, Garaix F, Lahoche A, Ulinski T, Harambat J, Couchoud C.

Nephrol Dial Transplant. 2014 Oct;29(10):1973-9. doi: 10.1093/ndt/gfu220. Epub 2014 Jun 30.

PMID:
24981582
32.

Proton Ordering of Cubic Ice Ic: Spectroscopy and Computer Simulations.

Geiger P, Dellago C, Macher M, Franchini C, Kresse G, Bernard J, Stern JN, Loerting T.

J Phys Chem C Nanomater Interfaces. 2014 May 22;118(20):10989-10997. Epub 2014 Apr 30.

33.

Improving mutation screening in familial hematuric nephropathies through next generation sequencing.

Morinière V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L.

J Am Soc Nephrol. 2014 Dec;25(12):2740-51. doi: 10.1681/ASN.2013080912. Epub 2014 May 22.

34.

The random phase approximation applied to ice.

Macher M, Klimeš J, Franchini C, Kresse G.

J Chem Phys. 2014 Feb 28;140(8):084502. doi: 10.1063/1.4865748.

PMID:
24588180
35.

[Dementia in Germany: results of an interdisciplinary expert workshop].

Blödt S, Kuhlmey A, Bartholomeyczik S, Behl C, Betsch F, Brinkhaus B, Frühwald M, Füsgen I, Jansen S, Köppel C, Krüger E, Macher M, Michalsen A, Rapp MA, Riepe MW, Schimpf D, Teut M, Warme B, Warning A, Wilkens J, Witt CM.

Wien Med Wochenschr. 2013 Dec;163(23-24):536-40. doi: 10.1007/s10354-013-0252-y. Epub 2013 Nov 22. German.

PMID:
24264454
36.

[ESRD in children and adolescents].

Harambat J, Hogan J, Macher MA, Couchoud C; registre du REIN.

Nephrol Ther. 2013 Sep;9 Suppl 1:S167-79. doi: 10.1016/S1769-7255(13)70044-0. French.

PMID:
24119580
37.

C3 nephritic factor associated with C3 glomerulopathy in children.

Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.

Pediatr Nephrol. 2014 Jan;29(1):85-94. doi: 10.1007/s00467-013-2605-6. Epub 2013 Sep 26.

PMID:
24068526
38.

Disparities in policies, practices and rates of pediatric kidney transplantation in Europe.

Harambat J, van Stralen KJ, Schaefer F, Grenda R, Jankauskiene A, Kostic M, Macher MA, Maxwell H, Puretic Z, Raes A, Rubik J, Sørensen SS, Toots U, Topaloglu R, Tönshoff B, Verrina E, Jager KJ.

Am J Transplant. 2013 Aug;13(8):2066-74. doi: 10.1111/ajt.12288. Epub 2013 May 29.

39.

Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population.

Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ; ESPN/ERA-EDTA Registry.

Nephrol Dial Transplant. 2013 Apr;28(4):1031-8. doi: 10.1093/ndt/gfs549. Epub 2013 Jan 8. Erratum in: Nephrol Dial Transplant. 2018 Mar 1;33(3):542.

PMID:
23300261
40.

[Children and adolescents with ESRD].

Harambat J, Macher MA, Niaudet P, Couchoud C.

Nephrol Ther. 2012 Sep;8 Suppl 1:S149-59. doi: 10.1016/S1769-7255(12)70032-9. French. No abstract available.

PMID:
23121925
41.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

42.

[Evolution of the access to the kidney transplantation in France of foreign patients and French patients living in overseas territories].

Cantrelle C, Pessione F, Macher MA, Thuong M.

Bull Soc Pathol Exot. 2012 May;105(2):115-22. doi: 10.1007/s13149-012-0221-5. Epub 2012 Feb 22. French.

PMID:
22359184
43.

Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.

Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.

Nephrol Dial Transplant. 2012 Mar;27(3):1083-9. doi: 10.1093/ndt/gfr405. Epub 2011 Aug 1.

PMID:
21810762
44.

Cyclophosphamide in steroid-dependent nephrotic syndrome.

Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Deschênes G, Baudouin V.

Pediatr Nephrol. 2011 Jun;26(6):927-32. doi: 10.1007/s00467-011-1830-0. Epub 2011 Mar 12.

PMID:
21394465
45.

[Outcome and outlook of living donor kidney transplantation activity in France].

Lamy FX, Savoye E, Macher MA, Thuong M.

Nephrol Ther. 2011 Dec;7(7):535-43. doi: 10.1016/j.nephro.2011.01.001. Epub 2011 Feb 9. French.

PMID:
21310675
46.

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.

Leroy V, Fremeaux-Bacchi V, Peuchmaur M, Baudouin V, Deschênes G, Macher MA, Loirat C.

Pediatr Nephrol. 2011 Mar;26(3):419-24. doi: 10.1007/s00467-010-1734-4. Epub 2010 Dec 25.

PMID:
21188423
47.

Mutational analysis of the PLCE1 gene in steroid resistant nephrotic syndrome.

Boyer O, Benoit G, Gribouval O, Nevo F, Pawtowski A, Bilge I, Bircan Z, Deschênes G, Guay-Woodford LM, Hall M, Macher MA, Soulami K, Stefanidis CJ, Weiss R, Loirat C, Gubler MC, Antignac C.

J Med Genet. 2010 Jul;47(7):445-52. doi: 10.1136/jmg.2009.076166.

48.

Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation.

Loirat C, Macher MA, Elmaleh-Berges M, Kwon T, Deschênes G, Goodship TH, Majoie C, Davin JC, Blanc R, Savatovsky J, Moret J, Fremeaux-Bacchi V.

Nephrol Dial Transplant. 2010 Oct;25(10):3421-5. doi: 10.1093/ndt/gfq319. Epub 2010 Jun 8.

PMID:
20530807
49.

Rituximab efficiency in children with steroid-dependent nephrotic syndrome.

Sellier-Leclerc AL, Macher MA, Loirat C, Guérin V, Watier H, Peuchmaur M, Baudouin V, Deschênes G.

Pediatr Nephrol. 2010 Jun;25(6):1109-15. doi: 10.1007/s00467-010-1465-6. Epub 2010 Mar 18.

PMID:
20238230
50.

Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.

Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P.

Kidney Int. 2010 Mar;77(5):443-9. doi: 10.1038/ki.2009.435. Epub 2009 Dec 16.

Supplemental Content

Loading ...
Support Center